Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS

por Fasano, Alfonso, García-Ramos, Rocío, Gurevich, Tanya, Jech, Robert, Bergmann, Lars, Sanchez-Soliño, Olga, Parra, Juan Carlos, Simu, Mihaela
Publicado 2023

Levodopa‐Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial

por Freire‐Alvarez, Eric, Kurča, Egon, Lopez Manzanares, Lydia, Pekkonen, Eero, Spanaki, Cleanthe, Vanni, Paola, Liu, Yang, Sánchez‐Soliño, Olga, Barbato, Luigi M.
Publicado 2021

EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study

por Kilpatrick, Ryan D., Sánchez-Soliño, Olga, Alami, Negar Niki, Johnson, Christopher, Fang, Yixin, Wegrzyn, Lani R., Krueger, Whitney S., Ye, Yizhou, Dreyer, Nancy, Gray, Gregory C.
Publicado 2022

Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study

por Fasano, Alfonso, Gurevich, Tanya, Jech, Robert, Kovács, Norbert, Svenningsson, Per, Szász, József, Parra, Juan Carlos, Bergmann, Lars, Johnson, Anita, Sanchez‐Soliño, Olga, Tang, Zhongwen, Vela‐Desojo, Lydia
Publicado 2021

Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson's Disease: INSIGHTS Study

por Chung, Sun Ju, Calopa, Matilde, Ceravolo, Maria G., Tambasco, Nicola, Antonini, Angelo, Chaudhuri, K. Ray, Robieson, Weining Z., Sánchez-Soliño, Olga, Zadikoff, Cindy, Jin, Man, Barbato, Luigi M.
Publicado 2022